Covishield Case: Bereaved parents to take Serum Institute of India to Court following AstraZeneca's rare side effect admission

The parents of a woman allegedly deceased after receiving the Covishield vaccine plan to file a case against the Serum Institute of India (SII). This decision follows AstraZeneca's acknowledgment in court that their Covid shot can cause a rare side effect, providing hope for the parents in seeking justice. AstraZeneca faces a class-action lawsuit over allegations that its vaccine, developed with the University of Oxford, led to deaths and serious injuries, including thrombosis with thrombocytopenia syndrome (TTS), characterized by blood clots and low platelet count.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/B1uRIk9
via IFTTT